THE ROLE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) AND PLASMINOGEN-ACTIVATOR INHIBITOR-2 (PAI-2) IN KERATINOCYTE PROLIFERATION

被引：0
|
作者：
HIBINO, T [1 ]
OONUMA, M [1 ]
TAKAHASHI, T [1 ]
HORII, I [1 ]
机构：
[1] SHISEIDO RES CTR,YOKOHAMA,JAPAN
来源：
CLINICAL RESEARCH | 1992年 / 40卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A514 / A514
页数：1
相关论文
共 50 条
  • [1] THE ROLE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) AND PALSMINOGEN ACTIVATOR INHIBITOR-2 (PAI-2) IN KERATINOCYTE PROLIFERATION
    HIBINO, T
    OONUMA, M
    TAKAHASHI, T
    HORII, I
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 98 (04) : 633 - 633
  • [2] CHARACTERIZATION OF THE BINDING OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) TO PLASMINOGEN, TO PLASMINOGEN-ACTIVATOR INHIBITOR-1 AND TO THE U-PA RECEPTOR
    LIJNEN, HR
    DECOCK, F
    COLLEN, D
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 224 (02): : 567 - 574
  • [3] AVIAN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) LACKS THE PUTATIVE BINDING-SITE FOR PLASMINOGEN-ACTIVATOR INHIBITOR (PAI) AND IS RESISTANT TO INHIBITION BY HUMAN PAI-1 AND PAI-2
    TESTA, JE
    STEFANSSON, S
    SIOUSSAT, T
    QUIGLEY, JP
    FIBRINOLYSIS, 1995, 9 (02) : 93 - 99
  • [4] CALCITRIOL-MEDIATED MODULATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-2
    KOLE, KL
    GYETKO, MR
    SIMPSON, RU
    SITRIN, RG
    BIOCHEMICAL PHARMACOLOGY, 1991, 41 (04) : 585 - 591
  • [5] THE KINETICS OF INHIBITION OF TISSUE-TYPE (T-PA) AND UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) BY 2 MOLECULAR-FORMS OF PLASMINOGEN-ACTIVATOR INHIBITOR 2 (PAI-2) - THE INFLUENCE OF FIBRIN
    THORSEN, S
    MADSEN, B
    RODER, M
    LECANDER, I
    ASTEDT, B
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 350 - 350
  • [6] PROGNOSTIC VALUE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) AND PLASMINOGEN-ACTIVATOR INHIBITORS PAI-1 AND PAI-2 IN BREAST CARCINOMAS
    BOUCHET, C
    SPYRATOS, F
    MARTIN, PM
    HACENE, K
    GENTILE, A
    OGLOBINE, J
    BRITISH JOURNAL OF CANCER, 1994, 69 (02) : 398 - 405
  • [7] PRONOSTIC VALUE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) AND PLASMINOGEN-ACTIVATOR INHIBITORS PAI-1 AND PAI-2 IN BREAST CARCINOMAS
    BOUCHET, C
    SPYRATOS, F
    MARTIN, PM
    HACENE, K
    GENTILE, A
    OGLOBINE, J
    BULLETIN DU CANCER, 1994, 81 (09) : 770 - 779
  • [8] DDAVP INDUCES SYSTEMIC RELEASE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA)
    LEVI, M
    TENCATE, JW
    DOOIJEWAARD, G
    STURK, A
    BROMMER, EJP
    AGNELLI, G
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 330 - 330
  • [9] THE PLASMINOGEN-ACTIVATOR UROKINASE AND ITS INHIBITOR PAI-2 IN ENDOMETRIAL CANCER
    GLEESON, N
    GONSALVES, R
    BONNAR, J
    GYNECOLOGIC ONCOLOGY, 1992, 47 (01) : 58 - 61
  • [10] Role of plasminogen activator inhibitor-2 (PAI-2) in keratinocyte differentiation
    Jang, Sunhyae
    Yang, Tae Ho
    An, Eun Jeong
    Yoon, Hyun Kyung
    Sohn, Kyung-Cheol
    Cho, Ah Young
    Ryu, Eun-Kyoung
    Park, Yeon-suk
    Yoon, Tae Young
    Lee, Jeung-Hoon
    Kim, Chang Deok
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2010, 59 (01) : 25 - 30
12345